The Drug Discovery Services Market is undergoing a transformative phase as pharmaceutical and biotechnology companies increasingly lean on outsourcing to streamline the complex journey from molecule to medicine. In 2025, the market is characterized by a heavy reliance on Contract Research Organizations (CROs) to mitigate the skyrocketing costs of in-house Research and Development...